Doctor of Osteopathy Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Larry Mathias

Vascular & Interventional Radiology Tulsa, OK Doctor of Osteopathy

NPI 1730534520 CMS profile 2256176

5801 E 41St St Ste 900, Tulsa, OK 74135

Open in the dashboard

General payments

$2,268

45 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Larry Mathias of Tulsa, OK is reported in the CMS Open Payments database as having received $2,268 across 45 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 46th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $296 10
2024 General $104 4
2023 General $856 12
2022 General $403 8
2021 General $507 9
2020 General $102 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Larry Mathias
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Larry Mathias were reported at $296. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Larry Mathias Vascular & Interventional Radiology median Middle half National median
2019 $0 $422 $125–$1,555 $163
2020 $102 $200 $68–$652 $114
2021 $507 $280 $99–$866 $132
2022 $403 $433 $137–$1,497 $149
2023 $856 $506 $152–$2,019 $160
2024 $104 $556 $175–$1,930 $164
2025 $296 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Balt USA, LLC $994 14 payments
  2. Surefire Medical, Inc. $456 14 payments
  3. Sirtex Medical Inc $153 3 payments
  4. Penumbra, Inc. $141 2 payments
  5. Boston Scientific Corporation $135 2 payments
  6. AngioDynamics, Inc. $123 2 payments
  7. Bard Peripheral Vascular, Inc. $102 2 payments
  8. Imperative Care, INc $63 2 payments
  9. Terumo Medical Corporation $37 2 payments
  10. Route 92 Medical, Inc. $33 1 payment
  11. Other $30 1 payment

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Food and Beverage $2,268 45 payments
Products named General payments · program years 2020–2025
  1. Prestige Coil System $606 7 payments
  2. TRINAV INFUSION SYSTEM $456 14 payments
  3. SIR-Spheres Microspheres $153 3 payments
  4. Indigo System $132 1 payment
  5. NanoKnife $110 1 payment
  6. General - Vascular Intervention $76 1 payment
  7. ZOOM 88-T LARGE DISTAL PLATFORM $63 2 payments
  8. EMBOLD Fibered $59 1 payment
  9. Azur CX Detachable $37 2 payments
  10. FLOWTRIEVER CATHETER, S $30 1 payment
  11. Other $52 3 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 212 billing codes

Paid by Medicare

$122,488

Of which drugs: $106

Medicare patients

1,011

Average age 74

Services billed

1,950

550 women, 461 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 51%
Chronic kidney disease 41%
Ischemic heart disease 39%
Diabetes 38%
Heart failure 33%
Depression 31%
Atrial fibrillation 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

45 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record